Skip to main content

Table 1 Baseline demographics

From: International Analgesia, Sedation, and Delirium Practices: a prospective cohort study

 

2010

n = 7323

2016

n = 6958

Age

63 (49–74)

64 (50–75)

Male

4571 (62%)

4347 (62%)

BMI

25.5 (22.9–28.9)

25.1 (22.6–28.3)

SAPSII

45 (33–58)

44 (32–58)

Region

 USA/Canada

825 (11.3%)

322 (4.6%)

 Europe

2931 (40.0%)

2677 (38.5%)

 Africa

133 (1.8%)

169 (2.4%)

 Asia

1226 (16.7%)

1816 (26.1%)

 Latin America

1576 (21.5%)

1809 (26.0%)

 Australia/New Zealand

632 (8.6%)

165 (2.4%)

Reason for ventilation

 COPD exacerbation

336 (4.6%)

323 (4.6%)

 Asthma

80 (1.1%)

44 (0.6%)

 Other chronic pulmonary disease

87 (1.2%)

116 (1.7%)

Comaa

 Metabolic

265 (3.8%)

287 (4.4%)

 Overdose/intoxication

211 (3.0%)

197 (3.0%)

 Hemorrhagic stroke

470 (6.7%)

434 (6.6%)

 Ischemic stroke

214 (3.1%)

199 (3.0%)

 Brain trauma

302 (4.3%)

378 (5.7%)

Neuromuscular disease

74 (1.0%)

93 (1.4%)

Acute respiratory failure

 ARDS

256 (3.5%)

284 (4.1%)

 Postoperative

1702 (23.2%)

1538 (22.1%)

 CHF

399 (5.4%)

346 (5.0%)

 Aspiration

188 (2.6%)

167 (2.4%)

 Pneumonia

697 (9.5%)

737 (10.6%)

 Sepsis

715 (9.8%)

700 (10.6%)

 Trauma

347 (4.7%)

296 (4.3%)

 Cardiac arrest

473 (6.8%)

443 (6.7%)

 Other ARF

400 (5.5%)

261 (3.8%)

  1. Continuous variables reported as median (IQR). Categorical variables reported as n (%)
  2. aComa subtype was missing in 341 and 384 patients in 2010 and 2016, respectively
  3. Definitions of abbreviations: ARDS acute respiratory distress syndrome, ARF acute respiratory failure, CHF congestive heart failure, BMI body mass index, SAPS simplified acute physiology score